| [1] |
韩晓鹏，许威，于建平，等. 腹腔镜胃癌根治术无瘤技术的应用研究[J]. 现代肿瘤医学，2015，23(21)：3128-3131.
|
| [2] |
何士英. 无瘤技术在结肠癌手术中的应用[J]. 医药前沿，2012，20(35)：189-190.
|
| [3] |
刘阳，李思. 腹腔镜直肠癌切除术中的无瘤技术[J]. 中国内镜杂志， 2008, 14 (4): 441-442.
|
| [4] |
Atkin G, Chopada A, Mitchell I. Colorectal cancer metastasis: in the surgeon′s hands[J]. Int Semin Surg Oncol, 2005, 2(1): 1-5.
|
| [5] |
Kuroki T, Eguchi S. No－touch isolation techniques for pancreatic cancer[J]. Surg Today, 2017, 47(1): 8-13.
|
| [6] |
Li Y, Xu KS, Li JS, et al. The research of no－touch isolation technique on the prevention of postoperative recurrence and metastasis of hepatocellular carcinoma after hepatectomy[J]. Hepatogastroenterology, 2014 , 61(131): 784-791.
|
| [7] |
童晓文，祁小龙，李怀芳. 妇科恶性肿瘤的腹腔镜手术治疗现状[J/CD]. 中华腔镜外科杂志(电子版), 2012，5(4)：8-12.
|
| [8] |
刘奕武，沈雄飞，程勇. 结肠癌完整结肠系膜切除研究进展[J]. 中国全科医学，2012，15(5)：585-587.
|
| [9] |
刘晓霞，李秀娟，张玉英，等. 保护性隔离措施在恶性肿瘤手术中的应用[J]. 中国现代药物应用，2010，4(7)：220-220.
|
| [10] |
Tamoto E, Hirano S, Tsuchikawa T, et al. Portal vein resection using theno－touchtechnique with a hepatectomy for hilar cholangiocarcinoma[J]. HPB (Oxford), 2014 , 16(1): 56-61.
|
| [11] |
Nishio H, Nagino M, Nimura Y. Surgical management of hilar cholangiocarcinoma: the nagoya experience[J]. HPB, 2005, 7(4): 259-262.
|
| [12] |
Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases[J]. Annals of Surgery, 2003, 238(5): 720-727.
|
| [13] |
吴晖，何裕隆. 胃癌根治术中的无瘤技术[J/CD]. 消化肿瘤杂志(电子版)，2013，5(4)：215-216.
|
| [14] |
Chernofsky MR, Felix JC, Muderspach LI, et al. Influence of quantity of lymph vascular space invasion on time to recurrence in women with early－stage squamous cancer of the cervix[J]. Gynecol Oncol, 2006, 100(2): 288-293.
|
| [15] |
Cheng L, Jones TD, Lin H, et al. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma[J]. J Urol, 2005, 174(6): 2181-2185.
|
| [16] |
Kikuchi E, Horiguchi Y, Nakashima J, et al. Lymphovascular invasion independently predicts increased disease specific survival in patients with transitional cell carcinoma of the upper urinary tract[J]. J Urol, 2005, 174(6): 2120-2123.
|